Kyung NAM Pharm

053950 · KOSDAQ · Health Care · SMALL CAP

A capital raise.

Kyung NAM Pharm disclosed a new share issuance to raise US$12.7M, about 47.9% of its market value.

Capital raise(Material event report (rights offering))· FILED 2026-05-21· RCEPT 20260521000617

US$12.7MRaise amount
47.9%vs. market value

Converted at 1 USD ≈ ₩1,504.4 (filing-date rate, 2026-05-21 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-10-12) →

What happened

Kyung NAM Pharm disclosed a new share issuance to raise US$12.7M, about 47.9% of its market value.

For context, this raise equals about 47.9% of the company's market value, which is the rough scale of potential new-share dilution.

InstrumentShare issuance
Raise amountUS$12.7M
vs. market value47.9%
Filed2026-05-21, Material event report (rights offering)
SourceDART rcept 20260521000617 → open original filing

Versions of this filing

  1. 2026-05-21Original (this page)
  2. 2026-06-23Amendment 1
  3. 2026-09-07Amendment 2
  4. 2026-09-18Amendment 3
  5. 2026-10-12Amendment 4

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-21 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.